You may be eligible to participate in a clinical research study evaluating a small, spring like implant designed to help people with severe emphysema breathe easier.
Now Enrolling
Do you have COPD and struggle with severe emphysema?
Check eligibility
• Investigational use only
• Voluntary participation
• Compensation provided
About the study
What is the BREATHE-3 clinical trial?
BREATHE-3 is a research study designed to assess the safety and efficacy of the Apreo BREATHE Airway Scaffold — a small implant placed in the lung and designed to gently tent open blocked airways, helping trapped air escape which may make it easier to breathe.
The implant in action
See how the BREATHE Airway Scaffold opens the airway
The Apreo BREATHE Airway Scaffold is designed to gently tent open blocked airways, helping trapped air escape which may make it easier to breathe.
CAUTION — Investigational Device. Limited by United States law to investigational use. Exclusively for clinical investigation.
Participation criteria
Who may be eligible?
Study participants must meet the below criteria.
Diagnosed with COPD or severe emphysema by a doctor
Currently receiving optimal medical management
Not actively smoked within 4 months and agrees to smoking cessation
Not significantly immunocompromised
Reduced lung function, even when using an inhaler or bronchodilator
Between 40 and 84 years of age
Willing and able to complete a supervised pulmonary rehab program or have already completed in the prior year
No prior lung surgery or implant in place
View the complete inclusion & exclusion criteria for study NCT06891755 on ClinicalTrials.gov.
How it works
What to expect from pre-screen to treatment
1
2
3
4
5
Quick pre-screen survey
Check eligibility
Thank you for your interest in this clinical study. The questions below will help determine whether the study might be an option for you.